Politician trade (Senate)

Boston Scientific (BSX): Sen. Markwayne Mullin disclosed a purchase $15K–$50K

Sen. Markwayne Mullin disclosed a purchase of Boston Scientific in the $15K–$50K range.

$15,001–$50,000
Reported range · official band, not an exact amount
29 days
Disclosure lag
Traded
Sep 13, 2023
Disclosed
Oct 12, 2023

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jul 27, 2023FDARecall: Guider Softip Guide Catheter 5F 100CM MULTI PURPOSE, Catalog number M003101630, cardiac guide catheter
  2. Jul 27, 2023FDARecall: Guider Softip Guide Catheter 8F 90CM MULTI PURPOSE, Catalog number H965100480, cardiac guide catheter
  3. Jul 27, 2023FDARecall: Guider Softip Guide Catheter 5F PRE-SHAPED 40 90CM, Catalog number M003100620, cardiac guide catheter
  4. Jul 27, 2023FDARecall: Guider Softip Guide Catheter 6F 90CM MULTI PURPOSE, Catalog number H965100460, cardiac guide catheter
  5. Sep 8, 2023Congress · 1 personMembers of Congress: 2 sales
  6. Sep 13, 2023 · this disclosureCongressDisclosed purchase of BSX — reported range $15,001 - $50,000

What came next

  1. Sep 27, 2023FDARecall: EXALT Model D Single-Use Duodenoscope: Outer box UPN# M00542420 & Outer box UPN# M0054242CE0.
  2. Sep 27, 2023FDARecall: EXALT Model D Single-Use Duodenoscope, 2 pack: Outer box UPN# M00542421, Inner box UPN # M00542420 & Outer box UPN# M0054242CE1, Inner box UPN # M0054242CE0.
  3. Oct 3, 2023CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  4. Oct 27, 2023FDAFDA device clearance: AXIOS Stent and Electrocautery-Enhanced Delivery System (6mmx8mm); AXIOS Stent and Electrocautery-Enhanced Delivery System (8mmx8mm); AXIOS Stent and Electroca…
  5. Oct 27, 2023FDAFDA device clearance: Polaris X™ Unidirectional Steerable Diagnostic Catheter
  6. Nov 22, 2023FDAFDA device clearance: IceSeed 1.5 CX 90º Needle (H7493967433170); IceSeed 1.5 CX S 90º Needle (H7493967233100)
  7. Nov 28, 2023FDAFDA device clearance: Gold Probe Bipolar Electrohemostasis Catheter; Injection Gold Probe Bipolar Electrohemostasis Catheter
  8. Nov 30, 2023FDAFDA device clearance: 14F iSLEEVE Introducer Set
  9. Nov 30, 2023FDARecall: Boston Scientific Model 3120 ZOOM LATITUDE Programmer/Recorder/Monitor (PRM) installed with Model 2892 Programmer Application Software used for the following p…
  10. Dec 4, 2023CongressDisclosed sale of BSX — reported range $1,001 - $15,000
  11. Dec 11, 2023FDAFDA device clearance: FARADRIVE™ Steerable Sheath
  12. Dec 12, 2023FDAFDA device clearance: StoneSmart Connect Console, LithoVue Elite Standard Deflection, LithoVue Elite Reverse Deflection
  13. Dec 19, 2023FDARecall: EndoVive Replacement Button Kit w/ ENFIT 28F 2.8 CM, Outer Box UPN M00509500 or M00509510.
View the official recordSenate eFD periodic transaction report

How to read Senate eFD periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Boston Scientific

For Boston Scientific, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 7 Congress trade reports, 1 fund holdings report (13F) and 5 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BSX page.

Other recent filings by Sen. Markwayne Mullin

The full history of Sen. Markwayne Mullin is on the profile page.

How this filing works

Explore the data

Other disclosures at Boston Scientific

Everything OQRO holds on this company is on its BSX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data